Stocks making the biggest moves midday: Harley-Davidson, Wingstop, Sarepta Therapeutics and more

Midday market activity saw several companies experience significant shifts, primarily driven by quarterly earnings and strategic updates. Harley-Davidson rallied 16% following a partnership to transform its financing arm into a capital-light model, while Wingstop surged 22% and Federal Signal 21% on strong Q2 results and raised full-year guidance. Teradyne also gained 19% with AI applications cited as a key growth driver. Conversely, Avis Budget Group fell 13% on a notable decline in Q2 GAAP earnings, and Novo Nordisk dropped 6% after cutting its full-year Wegovy sales outlook and announcing a leadership change.

Analysis

Midday trading activity reveals a market strongly rewarding companies that beat earnings estimates and provided positive forward-looking statements, while punishing those with signs of weakening fundamentals or guidance cuts. Several firms saw double-digit percentage gains driven by robust second-quarter results and upgraded full-year outlooks, including Wingstop (WING), which rallied over 22% after beating profit and revenue forecasts and raising its unit growth rate, and Federal Signal (FSS), which surged 21% on a similar beat-and-raise performance. Teradyne (TER) also soared 19%, with management explicitly attributing its strong results and optimistic H2 forecast to the artificial intelligence sector, specifically in Semiconductor Test and System-on-a-Chip applications. Other significant upward moves were catalyst-driven: Harley-Davidson (HOG) gained 16% on a strategic partnership to create a capital-light financing arm, and Peloton (PTON) jumped 17% following a UBS upgrade. Conversely, Avis Budget Group (CAR) slid 13% after its Q2 GAAP earnings plummeted to 10 cents per share from 41 cents a year prior. Novo Nordisk (NVO) fell 6% after it cut its full-year guidance for its key Wegovy drug, announced a CEO change, and received a downgrade to neutral from Bank of America, indicating significant headwinds. Mondelez (MDLZ) also slipped 6% on a mixed report where misses on organic growth and adjusted gross margin overshadowed beats on headline earnings and revenue, suggesting potential underlying weakness.

Key Decisions for Investors

• Investors should scrutinize the sustainability of momentum in stocks like Wingstop and Teradyne, as their rallies are supported by both strong Q2 performance and raised forward guidance, indicating robust business fundamentals.
• Caution is warranted for Novo Nordisk and Avis Budget Group, where guidance cuts, executive changes, and sharp earnings declines signal significant operational and competitive headwinds that may not be fully priced in.
• For companies with mixed results like Mondelez, it is crucial to look beyond headline earnings beats and analyze underlying metrics such as organic growth and margins for signs of potential deceleration.
• Consider that significant moves in Harley-Davidson, Sarepta Therapeutics, and Peloton were driven by non-earnings catalysts, which may present unique event-driven opportunities but require a different due diligence approach than traditional fundamental analysis.